Lupin is a USD 2.55 billion innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position...
Pharmaceutical Manufacturing,Drug Manufacturing & Research,Specialty Pharmaceuticals,Pharmaceuticals,APIs,Healthcare,Complex Generics,Biotechnology,Novel Drug Discovery and Development,Drug Delivery Systems